Back to top of page

HEAL Initiative: Team Research for Initial Translational Efforts in Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] (U19 Clinical Trial Not Allowed)

To apply for this grant, the following information is required:

1. Project Title: Provide a title for your research project.

2. Abstract: Write a summary of your proposed research project.

3. Introduction: Describe the background and rationale for developing non-addictive analgesic therapeutics for pain treatment.

4. Objectives: Clearly state the specific objectives of your research project.

5. Research Plan: Provide a detailed plan for developing assays, screening, and early optimization work to develop a non-addictive therapeutic for pain treatment. Include information on discovery and validation of pharmacodynamic markers efficacy and pharmacokinetic/pharmacodynamic (PK/PD) studies.

6. Relationship to RFA-NS-21-010: Explain how your project aligns with the entry criteria for the RFA-NS-21-010 HEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain.

7. Scientific Rationale: Present a rigorous biological rationale for the development of analgesics and scientifically sound assays. If data linking the therapeutic target(s) to the proposed pain indication is not available, provide a plan for developing this data.

8. Pain Conditions: Specify the pain conditions your project aims to address, such as acute pain, chronic pain, neuropathy, musculoskeletal pain, headache disorders, etc.

9. Team Members: Provide a list of the team members involved in the research project, including their qualifications and roles.

10. Budget: Outline the budget for your research project, including details on how the grant funds will be utilized.

11. Timeline: Present a timeline for the completion of different project milestones within the 5-year award period.

12. Expected Outcomes: Describe the expected outcomes of your research project and how it will contribute to the development of non-addictive analgesic therapeutics.

13. References: Include a list of references cited in the proposal.

14. Additional Supporting Documents: Any additional documents required for the application, such as CVs of team members, letters of collaboration, etc.

It is important to thoroughly review the specific requirements and guidelines provided by the funding organization.

Apply Now
Dollar sign symbol

Funding Amount

Clipboard symbol with a small checkmark bottom right

Eligible Applicants

Checkmark

Eligible Activities

Clock symbol

Deadline to Apply

Apply for Funding

88%

Approval rating across all Canadian funding programs

93%

Average time savings to our clients, compared to
businesses that apply for funding in-house
Woman on high chair reading a book in a small room with windows